Clinical trials for

Immune Thrombocytopenia

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AI-generated · Refreshed daily · Not medical advice.

RecruitingSafety & dosing

Tianjin, Tianjin Municipality, ChinaCheck eligibility →

RecruitingSafety & dosing

Tianjin, ChinaCheck eligibility →

RecruitingObservational

Boston, Massachusetts, United StatesCheck eligibility →

RecruitingLarge-scale testing

Ann Arbor, Michigan, United States +4 moreCheck eligibility →

RecruitingSafety & dosing

Tianjin, Tianjin Municipality, ChinaCheck eligibility →

RecruitingSafety & dosing

Tianjin, Tianjin Municipality, ChinaCheck eligibility →

RecruitingInterventional

Bologna, Italy +4 moreCheck eligibility →

RecruitingSafety & dosing

Beijing, Beijing Municipality, China +2 moreCheck eligibility →

RecruitingLarge-scale testing

São Paulo, São Paulo, Brazil +4 moreCheck eligibility →

RecruitingLarge-scale testing

Créteil, FranceCheck eligibility →

RecruitingEarly testing

Canberra, Australian Capital Territory, Australia +2 moreCheck eligibility →

RecruitingEarly testing / Safety & dosing

Los Angeles, California, United States +4 moreCheck eligibility →

RecruitingPost-approval study

Fujian, Fujian, ChinaCheck eligibility →

RecruitingSafety & dosing

Tianjin, Tianjin Municipality, ChinaCheck eligibility →

RecruitingInterventional

Amiens, France +4 moreCheck eligibility →

RecruitingLarge-scale testing

Recife, Pernambuco, Brazil +1 moreCheck eligibility →

RecruitingObservational

Milan, ItalyCheck eligibility →

RecruitingObservational

Seville, Andalusia, Spain +4 moreCheck eligibility →

RecruitingLarge-scale testing

Los Angeles, California, United States +4 moreCheck eligibility →

RecruitingObservational

A Coruña, A Coruña, Spain +4 moreCheck eligibility →

AI-generated · Refreshed daily · Not medical advice.

RecruitingSafety & dosing

Tianjin, Tianjin Municipality, ChinaCheck eligibility →

RecruitingSafety & dosing

Tianjin, ChinaCheck eligibility →

RecruitingObservational

Boston, Massachusetts, United StatesCheck eligibility →

RecruitingLarge-scale testing

Ann Arbor, Michigan, United States +4 moreCheck eligibility →

RecruitingSafety & dosing

Tianjin, Tianjin Municipality, ChinaCheck eligibility →

RecruitingSafety & dosing

Tianjin, Tianjin Municipality, ChinaCheck eligibility →

RecruitingInterventional

Bologna, Italy +4 moreCheck eligibility →

RecruitingSafety & dosing

Beijing, Beijing Municipality, China +2 moreCheck eligibility →

RecruitingLarge-scale testing

São Paulo, São Paulo, Brazil +4 moreCheck eligibility →

RecruitingLarge-scale testing

Créteil, FranceCheck eligibility →

RecruitingEarly testing

Canberra, Australian Capital Territory, Australia +2 moreCheck eligibility →

RecruitingEarly testing / Safety & dosing

Los Angeles, California, United States +4 moreCheck eligibility →

RecruitingPost-approval study

Fujian, Fujian, ChinaCheck eligibility →

RecruitingSafety & dosing

Tianjin, Tianjin Municipality, ChinaCheck eligibility →

RecruitingInterventional

Amiens, France +4 moreCheck eligibility →

RecruitingLarge-scale testing

Recife, Pernambuco, Brazil +1 moreCheck eligibility →

RecruitingObservational

Milan, ItalyCheck eligibility →

RecruitingObservational

Seville, Andalusia, Spain +4 moreCheck eligibility →

RecruitingLarge-scale testing

Los Angeles, California, United States +4 moreCheck eligibility →

RecruitingObservational

A Coruña, A Coruña, Spain +4 moreCheck eligibility →

110 trials · Recruiting

110

Trials actively recruiting patients for Immune Thrombocytopenia

Trial status

Phase

Location